The Reproductive Toxicity Studies Market is valued at USD 817.6 million in 2026 and is projected to reach USD 2,140.0 million by 2036, expanding at a CAGR of 10.1% from 2026 to 2036. Demand is being supported by regulatory safety requirements, expanding pharmaceutical development pipelines, increasing outsourcing of specialized toxicology programs, and the need to evaluate fertility and...